Filter By Unselect All

Sub Category Unselect See All

API Screening (5)

Chiral Resolution Screening (2)

Excipient Screening (15)

Overview (23)

Particle Size Reduction & Micronization (11)

Polymorph & Crystal Screening (17)

Salt Screening (8)

Solid State Characterization (4)

Solubility Assessment & Enhancement (18)

Sterile Liquid Formulation (1)

Structure Elucidation (2)

Taste Masking (9)

Country Unselect See All

Belgium (3)

Canada (1)

Colombia (1)

France (5)

Germany (2)

Greece (1)

India (16)

New Zealand (1)

Portugal (1)

Romania (1)

Slovakia (slovak Republic) (1)

Spain (2)

Switzerland (1)

United Kingdom (5)

United States (12)

Companies Unselect See All

AbbVie Contract (1)

Advinus Therapeutics (1)

Aesica Pharmaceuticals (1)

Aizant Drug Research (1)

AMRI (1)

Anacipher (1)

Appco Pharmaceutical (1)

Ascent Innovative (1)

AvacaPharma (1)

Biophore India Pharmaceuticals (1)

BLUEPHARMA - INDUSTRIA (1)

Capsugel (1)

Catalent Pharma (1)

Crenza Pharma (1)

Crystec Pharma (1)

Custom Pharma (1)

Dalton Pharma (1)

Diverchim S.A. (1)

Eurofins CDMO (1)

GALENIX INNOVATIONS (1)

GfM mbH Gesellschaft (1)

Glatt Pharmaceutical (1)

Globela Pharma Pvt. (1)

GRAM Laboratory (1)

GVK Biosciences (1)

Iosynth Labs Pvt. (1)

Labiana Life Sciences (1)

M2M Pharmaceuticals (1)

Maithili Life Sciences (1)

Merck Millipore (1)

Mithra CDMO (1)

mKnal Global (1)

Olive Healthcare (1)

One Pharma S.A (1)

Orbis Biosciences, (1)

Particle Sciences (1)

PCI Synthesis (1)

Pfanstiehl, Inc (1)

PharmaVize NV (1)

Pierre Fabre (1)

Progenerics Pharma (1)

PSR Pharma Science (1)

Quotient Sciences (1)

Ropack Inc (1)

Saneca Pharmaceuticals (1)

Santa S.A (1)

Siegfried AG (1)

Skyepharma (1)

Softigel Procaps (1)

Stason Pharmaceuticals, (1)

Sushen Medicamentos (1)

UQUIFA (1)

Zenvision Pharma (1)

Selected Filter(s): Reset All

  • Category
    • Reset
  • Sub Category
    • Reset
  • Country
    • Reset

Contact

Drugs Excipient Compatibility Study

API & Drug Product Development >> Preformulation & Material Science >> Excipient Screening

Ascents offerings includes binary or ternary mixtures of API with excipients from various functional categories such as diluents, binders, glidants, disintegrants, lubricants etc., packaging material compatibility studies, selection of excipients etc.

Drugs Excipient Compatibility Study

Contact

Microfluidizer Technology

API & Drug Product Development >> Preformulation & Material Science >> Particle Size Reduction & Micronization

By using microfluidization technology process, Skyepharma provides solution to increase bioavailabity of poorly soluble APIs. It is also an interesting technology for micro and nano emulsion manufacturing.

Skyepharma-Microfluidizer-Technolog

Contact

Characterizing & Modifying Drug Substances Properties

API & Drug Product Development >> Preformulation & Material Science >> Overview

With expertise in characterizing and modifying a drug substance’s physical, chemical and mechanical properties, our objective is to help you assess and choose the best solid form for progression into animal and human dosing trials.

AMRI-Characterizing-Modifying-Drug

Contact

Solubility-Enhanced Dosage Forms Development

API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

Quotient Sciences has almost 30 years of experience developing a breadth of formulations across a range of indications.

Contact

Polymorph Development

API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening

Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.

Biophore-Polymorph-Development

Contact

Solid State

API & Drug Product Development >> Preformulation & Material Science >> Solid State Characterization

Eurofins CDMO has expanded its capabilities through Solid State Research and Development (SSRD) services in support of API developmental programs.

Eurofins-CDMO-Solid-State

Contact

Polymorphism Studies

API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening

Uquifa offers the opportunity to manage the development activities of any drug life cycle by offering services on DMF/CTD/COS application, stability studies, process validation and analytical method validation, working standard supply or impurity

Uquifa-Polymorphism-Studies

Contact

Solubility Screening / Bio-Availability

API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

Solubility screening, bio-availability enhancement to accelerate your drug development and approval.

Contact

Solubility Studies

API & Drug Product Development >> Preformulation & Material Science >> Sterile Liquid Formulation

PSR has necessary expertise & access to advanced technologies to develop the formulation and also, through the use of targeted analytics, supply the client with the relevant information needed to aid in the correct selection of formulation/drug delivery system to meet the clients requirements.

Contact

Pre-Formulation Studies

API & Drug Product Development >> Preformulation & Material Science >> Overview

Crenza is a full scale R&D centre for development of Parenteral and Ophthalmic drug products. Crenza is founded by Industry professionals with invaluable experience and proven track record of development and commercialization of Parenteral and Ophthalmic drug products for regulated markets.

PharmaCompass